Genetics of diabetic nephropathy

Therapeutic Advances in Cardiovascular Disease

Volumn 2, Issue 5, 2008, Pages 363-371

  Maeda, Shiro ^a  

^a RIKEN   (Japan)

Author keywords

Diabetic Nephropathy; Genome Wide Association Study; Single Nucleotide Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALDEHYDE REDUCTASE; AMINOACYLHISTIDINE DIPEPTIDASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR5; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE; ENGULFMENT AND CELL MOTILITY 1 PROTEIN; ENZYME; ESTROGEN RECEPTOR ALPHA; GLUCOSE TRANSPORTER 1; MANGANESE SUPEROXIDE DISMUTASE; NEUROCALCIN; NEUROCALCIN D; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHODIESTERASE I; PROTEIN DERIVATIVE; PROTEIN KINASE C BETA; SODIUM CHLORIDE COTRANSPORTER; SUMO 4 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME 1Q; CHROMOSOME 20P; CHROMOSOME 22Q; CHROMOSOME 2P; CHROMOSOME 2Q; CHROMOSOME 3Q; CHROMOSOME 5Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME 9Q; DIABETIC NEPHROPATHY; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE MAP; HUMAN; HUMAN GENOME; MICROSATELLITE MARKER; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETIC NEPHROPATHIES; GENOMICS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 68749097487     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944708094768     Document Type: Review

References (80)

1. Al-Kateb, H., Boright, A.P., Mirea, L., Xie, X., Sutradhar, R., Mowjoodi, A. et al. (2008) Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the diabetes control and complications trial / epidemiology of diabetes interventions and complications genetics study. Diabetes 57: 218-228.
2. Araki, S., Moczulski, D.K., Hanna, L., Scott, L.J., Warram, J.H. and Krolewski, A.S. (2000) APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes 49: 2190-2195.
3. Araki, S., Ng, D.P., Krolewski, B., Wyrwicz, L., Rogus, J.J., Canani, L. et al. (2003) Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus. J Am Soc Nephrol 14: 2015-2024.
4. Araki, S., Haneda, M., Sugimoto, T., Isono, M., Isshiki, K., Kashiwagi, A. et al. (2005) Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 54: 2983-2987.
5. Bowden, D.W., Colicigno, C.J., Langefeld, C.D., Sale, M.M., Williams, A., Anderson, P.J. et al. (2004) A genome scan for diabetic nephropathy in African Americans. Kidney Int 66: 1517-1526.
6. Brownlee, M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625.
7. Brugnera, E., Haney, L., Grimsley, C., Lu, M., Walk, S.F., Tosello-Trampont, A.C. et al. (2002) Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nature Cell Biol 4: 574-582.
8. Canani, L.H., Ng, D.P., Smiles, A., Rogus, J.J., Warram, J.H. and Krolewski, A.S. (2002) Polymorphism in ecto-nucleotide pyrophosphatase / phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 51: 1188-1193.
9. Fava, S., Azzopardi, J., Hattersley, A.T. and Watkins, P.J. (2000) Increased prevalence of proteinuria in diabetic sibs of proteinuric type 2 diabetic subjects. Am J Kidney Dis 35: 708-712.
10. Foley, R.N. and Colins, A.J. (2007) End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 18: 2644-2648.
11. Freire, M.B., Ji, L., Onuma, T., Orban, T., Warram, J.H. and Krolewski, A.S. (1998) Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 31: 896-899.
12. Fujisawa, T., Ikegami, H., Kawaguchi, Y., Hamada, Y., Ueda, H., Shintani, M. et al. (1998) Meta-analysis of association of insertion / deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41: 47-53.
13. Gaede, P., Vedel, P., Larsen, N., Jensen, G.V., Parving, H.H. and Pedersen, O. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383-393.
14. Gaede, P., Tarnow, L., Vedel, P., Parving, H.H. and Pedersen, O. (2004) Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 19: 2784-2788.
15. Goodkin, D.A., Bragg-Gresham, J.L., Koenig, K.G., Wolfe, R.A., Akiba, T., Andreucci, V.E. et al. (2003) Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14: 3270-3277.
16. Gumienny, T.L., Brugnera, E., Tosello-Trampont, A.C., Kinchen, J.M., Haney, L.B. et al. (2001) CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 107: 27-41.
17. Haga, H., Yamada, R., Ohnishi, Y., Nakamura, Y. and Tanaka, T. (2002) Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variation in the human genome. J Hum Genet 47: 605-610.
18. Hanson, R.L., Craig, D.W., Millis, M.P., Yeatts, K.A., Kobes, S., Pearson, J.V. et al. (2007) Identification of PVT 1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56: 975-983.
19. Hirakawa, M., Tanaka, T., Hashimoto, Y., Kuroda, M., Takagi, T. and Nakamura, Y. (2002) JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res 30: 158-162.
20. Imperatore, G., Hanson, R.L., Pettitt, D.J., Kobes, S., Bennett, P.H. and Knowler, W.C. (1998) Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 47: 821-830.
21. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945.
22. Jacobsen, P., Tarnow, L., Carstensen, B., Hovind, P., Poirier, O. and Parving, H.H. (2003) Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 14: 2843-2850.
23. Janssen, B., Hohenadel, D., Brinkkoetter, P., Peters, V., Rind, N., Fischer, C. et al. (2005) Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54: 2320-2327.
24. Jorsal, A., Tarnow, L., Lajer, M., Ek, J., Hansen, T., Pedersen, O., et al., (2008) The PPARgamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy. Mol Genet Metab May 6 [Epub ahead of print].
25. Kamiyama, M., Kobayashi, M., Araki, S., Iida, A., Tsunoda, T., Kawai, K. et al. (2007) Polymorphisms in the 3' UTR in the neurocalcin δ gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Human Genet 122: 397-407.
26. Keene, K.L., Mychaleckyj, J.C., Smith, S.G., Leak, T.S., Perlegas, P.S., Langefeld, C.D. et al. (2008) Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population. Hum Genet 123: 333-341.
27. Kim, J.H., Shin, H.D., Park, B.L., Moon, M.K., Cho, Y.M., Hwang, Y.H. et al. (2006) SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy. Diabetes 55: 843-848.
28. Krolewski, A.S., Warram, J.H., Rand, L.I. and Kahn, C.R. (1987) Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med 317: 1390-1398.
29. Krolewski, A.S., Poznik, G.D., Placha, G., Canani, L., Dunn, J., Walker, W. et al. (2006) A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 69: 129-136.
30. Lin, H.Y., Wang, C.L., Hsiao, P.J., Lu, Y.C., Chen, S.Y., Lin, K.D. et al. (2007) SUMO 4M55V variant is associated with diabetic nephropathy in type 2 diabetes. Diabetes 56: 1177-1180.
31. Liu, Y. (2004) Epithelial mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12.
32. Lyengar, S.K., Abboud, H.E., Goddard, K.A., Saad, M.F., Adler, S.G., Arar, N.H. et al. (2007) Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 56: 1577-1585.
33. Maeda, S., Haneda, M., Yasuda, H., Tachikawa, T., Isshiki, K., Koya, D. et al. (1999) Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes. Diabetes 48: 420-422.
34. Maeda, S., Haneda, M., Guo, B., Koya, D., Hayashi, K., Sugimoto, T. et al. (2001) Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with nephropathy in Japanese subjects with type 2 diabetes. Kidney Int 60: 1428-1434.
35. Maeda, S. (2004) Genome-wide search for susceptibility gene to diabetic nephropathy by gene-based SNP. Diabetes Res Clin Pract 66(Suppl 1): S45-S47.
36. Maeda, S., Osawa, N., Hayashi, T., Tsukada, S., Kobayashi, M. and Kikkawa, R. (2007) Genetic variations associated with diabetic nephropathy and type 2 diabetes in a Japanese population. Kidney Int 72: S43-S48.
37. Marre, M., Jeunemaitre, X., Gallois, Y., Rodier, M., Chatellier, G., Sert, C. et al. (1997) Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99: 1585-1595.
38. McKnight, A.J., Maxwell, A.P., Sawcer, S., Compston, A., Setakis, E., Patterson, C.C. et al. (2006) A genome-wide DNA microsatellite association screen to identify chromosomal regions harboring candidate genes in diabetic nephropathy. J Am Soc Nephrol 17: 831-836.
39. Mizuiri, S., Hemmi, H., Kumanomidou, H., Iwamoto, M., Miyagi, M., Sakai, K. et al. (2001) Angiotensin-converting enzyme (ACE) I / D genotype and renal ACE gene expression. Kidney Int 60: 1124-1130.
40. Moczulski, D.K., Rogus, J.J., Antonellis, A., Warram, J.H. and Krolewski, A.S. (1998) Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 47: 1164-1169.
41. Nakai, S., Shinzato, T., Nagura, Y., Masakane, I., Kitaoka, T., Shinoda, T. et al. (2004) An overview of regular dialysis treatment in Japan (as of 31 December 2001) Ther Apher Dial 8: 3-32.
42. Nakajima, K., Tanaka, Y., Nomiyama, T., Ogihara, T., Piao, L., Sakai, K. et al. (2002) Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes. Diabetes 51: 238-242.
43. Navarro-González, J.F. and Mora-Fernández, C. (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19: 433-442.
44. Ng, D.P., Warram, J.H. and Krolewski, A.S. (2003) TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants. Am J Kidney Dis 41: 22-28.
45. Ng, D.P., Tai, B.C., Koh, D., Tan, K.W. and Chia, K.S. (2005) Angiotensin-I converting enzyme insertion / deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 48: 1008-1016.
46. Ng, D.P., Placha, G., Choo, S., Chia, K.S., Warram, J.H. and Krolewski, A.S. (2006) A disease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus. Diabetes 55: 2660-2663.
47. Ng, D.P., Nurbaya, S., Choo, S., Koh, D., Chia, K.S. and Krolewski, A.S. (2008) Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes. Nephrol Dial Transplant 23 (7): 2260-4. [Epub Feb 10 2008].
48. Nishiyama, K., Tanaka, Y., Nakajima, K., Mokubo, A., Atsumi, Y., Matsuoka, K. et al. (2005) Polymorphism of the solute carrier family 12 (sodium/ chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitudinal study. Diabetologia 48: 1335-1338.
49. Nomiyama, T., Tanaka, Y., Piao, L., Nagasaka, K., Sakai, K., Ogihara, T. et al. (2003) The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 48: 138-141.
50. Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S. et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.
51. Ohnishi, Y., Tanaka, T., Ozaki, K., Yamada, R., Suzuki, H. and Nakamura, Y. (2001) A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 46: 471-477.
52. Osawa, N., Koya, D., Araki, S., Uzu, T., Tsunoda, T., Kashiwagi, A. et al. (2007) Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 52: 143-151.
53. Osterholm, A.M., He, B., Pitkaniemi, J., Albinsson, L., Berg, T., Sarti, C. et al. (2007) Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int 71: 140-145.
54. Perkins, B.A., Ficociello, L.H., Silva, K.H., Finkelstein, D.M., Warram, J.H. and Krolewski, A.S. (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348: 2285-2293.
55. Placha, G., Poznik, G.D., Dunn, J., Smiles, A., Krolewski, B., Glew, T. et al. (2006) A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes 55: 3358-3365.
56. Quinn, M., Angelico, M.C., Warram, J.H. and Krolewski, A.S. (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945.
57. Rayner, H.C., Pisoni, R.L., Bommer, J., Canaud, B., Hecking, E., Locatelli, F. et al. (2004) Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 19: 108-120.
58. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F. (1990) An insertion / deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346.
59. Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I. and Chen, H. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
60. Schelling, J.R., Abboud, H.E., Nicholas, S.B., Pahl, M.V., Sedor, J.R., Adler, S.G. et al. (2008) Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 57: 235-243.
61. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L. et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple suceptibility variants. Science 316: 1341-1345.
62. Shimazaki, A., Kawamura, Y., Kanazawa, A., Sekine, A., Saito, S., Tsunoda, T. et al. (2005) Genetic variations in the gene encoding ELMO 1 are associated with susceptibility to diabetic nephropathy. Diabetes 54: 1171-1178.
63. Shimazaki, A., Tanaka, Y., Shinosaki, T., Ikeda, M., Watada, H., Hirose, H. et al. (2006) ELMO 1 increases expression of extracellular matrix (ECM) proteins and inhibits cell adhesion to ECMs. Kidney Int 70: 1769-1776.
64. Simon, D.B., Nelson-Williams, C., Johnson-Bia, M., Ellison, D., Karet, F.E., Morey-Molina, A. et al. (1996) Gitelman's variant of Bartters syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nait Genet 12: 24-30.
65. Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D. et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885.
66. Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G.B. et al. (2007) A variant in CDKAL 1 influences insulin response and risk of type 2 diabetes. Nat Genet 39: 770-775.
67. Tanaka, N., Babazono, T., Saito, S., Sekine, A., Tsunoda, T., Haneda, M. et al. (2003) The association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of SNPs. Diabetes 52: 2848-2853.
68. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
69. The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437: 1299-1320.
70. Tomino, Y., Makita, Y., Shike, T., Gohda, T., Haneda, M., Kikkawa, R. et al. (1999) Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 82: 139-144.
71. UK Prospective Diabetes Study (UKPDS) Group ( 1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 352: 837-853.
72. Vardarli, I., Baier, L.J., Hanson, R.L., Akkoyun, I., Fischer, C., Rohmeiss, P. et al. (2002) Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62: 2176-2183.
73. Vionnet, N., Tregouët, D., Kazeem, G., Gut, I., Groop, P.H., Tarnow, L. et al. (2006) Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 55: 3166-3174.
74. Xu, M., Chen, X., Yan, L., Cheng, H. and Chen, W. (2008) Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis. J Mol Endocrinol 40: 243-251.
75. Zanchi, A., Moczulski, D.K., Hanna, L.S., Wantman, M., Warram, J.H. et al. (2000) Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57: 405-413.
76. Zeggini, E., Weedon, M.N., Lindgren, C.M., Frayling, T.M., Elliott, K.S., Lango, H. et al. (2007) Replication of genome-wide association signal in U.K. samples reveals risk loci for type 2 diabetes. Science 316: 1336-1341.
77. Zeggini, E., Scott, L.J., Saxena, R., Voight, B.F., Marchini, J.L., Hu, T. et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 25 (2) 35-40. March 30; [Epub ahead of print].
78. Zintzaras, E. and Stefanidis, I. (2005) Association between the GLUT 1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet 50: 84-91.
79. Zintzaras, E., Uhlig, K., Koukoulis, G.N., Papathanasiou, A.A. and Stefanidis, I. (2007) Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 52: 881-890.
80. Zychma, M.J., Zukowska-Szczechowska, E., Lacka, B.I. and Grzeszczak, W. (2000) Angiotensinogen M235T and chymase gene CMA / B polymorphisms are not associated with nephropathy in type II diabetes. Nephrol Dial Transplant 15: 1965-1970.